Pharma Pulse 8/22/24: OM1 Appoints New President, Navigating Global Regulatory Hurdles & more

How to Navigate Global Regulatory Hurdles to Successfully Launch a Medical Device

Manufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.

Study Finds Ketogenic Diets May Increase “Bad” Cholesterol

Pharmacists are key resource points to navigate the nuances of keto diets and chronic health management.

AstraZeneca Is a Cancer Leader. Obesity Could Be a Bonus.

AstraZeneca remains one of the best bets in Big Pharma, and potential success in obesity isn’t priced in to the stock.

OM1 Appoints Catherine Richards as President

OM1 announced the appointment of Catherine Richards, PhD, MPH, as its first President. Richards will oversee the Product, Engineering, Clinical Informatics, Client Services, Data Science, and Research teams. Her leadership will be pivotal in advancing OM1’s strategy, innovation, and collaboration to improve patient outcomes.

UpScriptHealth on LinkedIn

Our Founder & CEO Peter Ax explained why the latest drug shortages are a "perfect storm" in his recent interview with Pharmaceutical Commerce Magazine.

https://lnkd.in/gfWrnwUG

#drugshortages #supplychain

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs